Since its designation in 1999 by the National Cancer Institute (NCI), the Cancer Center has maintained a number of basic, clinical, translational and population science research programs — each designed to coordinate research opportunities across specific cancer types. In this time, these programs have been adjusted to accommodate the accelerating pace of discoveries in basic science and therapeutics -- such as cancer genetics and immunotherapy – and allowed us to pursue innovation while adhering to NCI requirements.
For example, in 2007, we expanded programs to include an infrastructure for experimental therapies, including the launch of an early-phase trials unit and improved efforts in medical informatics.
In December 2020, the NCI-supported programs were reconfigured again. This time from ten programs into seven. Leadership for these programs has changed and expanded to include program co-leaders and newly-appointed liaisons for Community Engagement and Outreach and Education.
"The new integration between the NCI-supported programs with the Office of Community Engagement and the Office of Education will provide enhanced capabilities to consider the needs of the communities we serve in all phases of research and better fulfill our education and training mission.
President Alan Ashworth, PhDView the new roster of research program leadership.